Literature DB >> 11377666

Progression, remission, regression of chronic renal diseases.

P Ruggenenti1, A Schieppati, G Remuzzi.   

Abstract

The prevalence of chronic renal disease is increasing worldwide. Most chronic nephropathies lack a specific treatment and progress relentlessly to end-stage renal disease. However, research in animals and people has helped our understanding of the mechanisms of this progression and has indicated possible preventive methods. The notion of renoprotection is developing into a combined approach to renal diseases, the main measures being pharmacological control of blood pressure and reduction of proteinuria. Lowering of blood lipids, smoking cessation, and tight glucose control for diabetes also form part of the multimodal protocol for management of renal patients. With available treatments, dialysis can be postponed for many patients with chronic nephropathies, but the real goal has to be less dialysis-in other words remission of disease and regression of structural damage to the kidney. Experimental and clinical data lend support to the notion that less dialysis (and maybe none for some patients) is at least possible.

Entities:  

Mesh:

Year:  2001        PMID: 11377666     DOI: 10.1016/S0140-6736(00)04728-0

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  83 in total

Review 1.  Management of hepatitis C in patients with chronic kidney disease.

Authors:  Mohammad A B Al-Freah; Zeino Zeino; Michael A Heneghan
Journal:  Curr Gastroenterol Rep       Date:  2012-02

2.  Transforming growth factor-beta1 is up-regulated by podocytes in response to excess intraglomerular passage of proteins: a central pathway in progressive glomerulosclerosis.

Authors:  Mauro Abbate; Carla Zoja; Marina Morigi; Daniela Rottoli; Stefania Angioletti; Susanna Tomasoni; Cristina Zanchi; Lorena Longaretti; Roberta Donadelli; Giuseppe Remuzzi
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

3.  Resistive index predicts renal prognosis in chronic kidney disease: results of a 4-year follow-up.

Authors:  Toshihiro Sugiura; Akira Wada
Journal:  Clin Exp Nephrol       Date:  2010-11-11       Impact factor: 2.801

4.  Diabetes and hypertension have become leading causes of CKD in Chinese elderly patients: a comparison between 1990-1991 and 2009-2010.

Authors:  Yali Cao; Wenge Li; Guannan Yang; Yutian Liu; Xin Li
Journal:  Int Urol Nephrol       Date:  2012-05-31       Impact factor: 2.370

5.  Animal models of regression/progression of kidney disease.

Authors:  Beom Jin Lim; Hai-Chun Yang; Agnes B Fogo
Journal:  Drug Discov Today Dis Models       Date:  2014

Review 6.  Renal protection in hypertensive patients: selection of antihypertensive therapy.

Authors:  René R Wenzel
Journal:  Drugs       Date:  2005       Impact factor: 9.546

7.  [Tackling lipaemia in diabetes mellitus in primary care].

Authors:  C Llor Vilà
Journal:  Aten Primaria       Date:  2003       Impact factor: 1.137

8.  Risk factors for renal failure in children with non-glomerular nephropathies.

Authors:  Mieczysław Litwin
Journal:  Pediatr Nephrol       Date:  2003-12-18       Impact factor: 3.714

9.  A mutation in the mouse Chd2 chromatin remodeling enzyme results in a complex renal phenotype.

Authors:  Concetta G A Marfella; Nils Henninger; Scott E LeBlanc; Namrata Krishnan; David S Garlick; Lawrence B Holzman; Anthony N Imbalzano
Journal:  Kidney Blood Press Res       Date:  2009-01-14       Impact factor: 2.687

10.  Improvement in eGFR in patients with chronic kidney disease attending a nephrology clinic.

Authors:  Hulya Taskapan; Paul Tam; Victoria Au; Stephen Chow; Jason Fung; Gordon Nagai; Janet Roscoe; Paul Ng; Tabo Sikaneta; Robert Ting; Dimitrios G Oreopoulos
Journal:  Int Urol Nephrol       Date:  2008-04-02       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.